Pfizer To Buy Serenex In A Cancer Drug Move

Armen Hareyan's picture

In a move to bolster its cancer treatment drug supply Pfizer said that it has reached a deal with Serenex to buy the pharmaceutical drug company.


Serenex is NC based drug company that owns the rights to a drug that treats cancer tumors and fights cancers of the blood, lymph nodes and bone marrow. The drug, SNX-5422, is currently in phase I trials, the earliest of the three stages of human testing. Pfizer also will acquire Serenex's drug discovery technology.

On February 27,

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.